AiM  Vol.5 No.7 , July 2015
Genotyping of New and Old Proteus mirabilis Isolates from Mansoura Hospitals in Egypt by rpoB Sequence Analysis
Abstract: Sequence analysis of the RNA polymerase B subunit encoding gene (rpoB) has been proposed as a useful tool for bacterial identification. This method has been implemented to differentiate five well-defined Proteus species: P. mirabilis, P. hauseri, P. penneri, P. vulgaris, and P. myxofaciens. In this study, we evaluated the usefulness of rpoB sequencing for intraspecies discrimination of P. mirabilis. The sequence of rpoB 909 bp region was analyzed in 15 newly isolated strains and 5 of 8 years old isolates from different clinical sources. Three respective groups were obtained. The first group included 13 of the new strains showing similarity with Proteus mirabilis (ATCC 29906) strain. The second group including 3 of the old strains differs from the first group with a divergence of 0.22%. Group 3 contains only a single new strain 33. The sequence of this strain shows differences in the rpoB 909 bp region analyzed from the members of group 1 and the second group by 1.65% and 1.87% divergence respectively. According to our results, genetic differences could be detected within the P. mirabilis species. Therefore much more effort should be made to re-evaluate rpoB method and validate its usefulness as a molecular diagnostic method.
Cite this paper: El-Sokkary, M. (2015) Genotyping of New and Old Proteus mirabilis Isolates from Mansoura Hospitals in Egypt by rpoB Sequence Analysis. Advances in Microbiology, 5, 549-554. doi: 10.4236/aim.2015.57057.

[1]   O’Hara, C.M., Brenner, F.W. and Miller, J.M. (2000) Classification, Identification, and Clinical Significance of Proteus, Providencia, and Morganella. Clinical Microbiology Reviews, 13, 534-546.

[2]   Rather, P.N. (2005) Swarmer Cell Differentiation in Proteus mirabilis. Environmental Microbiology, 7, 1065-1073.

[3]   Rózalski, A., Sidorczyk, Z. and Kotelko, K. (1997) Potential Virulence Factors of Proteus bacilli. Microbiology and Molecular Biology Reviews, 61, 65-89.

[4]   Mobley, H.L. and Belas, R. (1995) Swarming and Pathogenicity of Proteus mirabilis in the Urinary Tract. Trends in Microbiology, 3, 280-284.

[5]   Luzzaro, F., Vigano, E.F., Fossati, D., Grossi, A., Sala, A., Sturla, C., Saudelli, M. and Toniolo, A. (2002) Prevalence and Drug Susceptibility of Pathogens Causing Bloodstream Infections in Northern Italy: A Two-Year Study in 16 Hospitals. European Journal of Clinical Microbiology and Infectious Diseases, 21, 849-855.

[6]   Daza, R., Gutierrez, J. and Piedrola, G. (2001) Antibiotic Susceptibility of Bacterial Strains Isolated from Patients with Community-Acquired Urinary Tract Infections. International Journal of Antimicrobial Agents, 18, 211-215.

[7]   Grahnquist, L., Lundberg, B. and Tullus, K. (1992) Neonatal Proteus meningoencephalitis. Case Report. Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 100, 734-736.

[8]   Watanakunakorn, C. and Pernis, S.C. (1994) Protues mirabilis Bacteremia: A Review of 176 Cases during 1980-1992. Scandinavian Journal of Infectious Diseases. Supplementum, 26, 361-367.

[9]   Isenstein, D. and Honig, E. (1990) Proteus vulgaris Empyema and Increased Pleural Fluid pH. Chest, 97, 511.

[10]   de Champs, C., Bonnet, R., Sirot, D., Chanal, C. and Sirot, J. (2000) Clinical Relevance of Proteus mirabilis in Hospital Patients: A Two Year Survey. The Journal of Antimicrobial Chemotherapy, 45, 537-539.

[11]   Chen, C.Y., Chen, Y.H., Lu, P.L., Lin, W.R., Chen, T.C. and Lin, C.Y. (2012) Proteus mirabilis Urinary Tract Infection and Bacteremia: Risk Factors, Clinical Presentation, and Outcomes. Journal of Microbiology, Immunology and Infection, 45, 228-236.

[12]   Woese, C.R., Kandler, O. and Wheelis, M.L. (1990) Towards a Natural System of Organisms: Proposal for the Domains Archaea, Bacteria, and Eucarya. Proceedings of the National Academy of Sciences of the United States of America, 87, 4576-4579.

[13]   Mollet, C., Drancourt, M. and Raoult, D. (1997) rpoB Sequence Analysis as a Novel Basis for Bacterial Identification. Molecular Microbiology, 26, 1005-1011.

[14]   Ojeniyi, B. (1988) Bacteriophages in Sputum of Cystic Fibrosis Patients as a Possible Cause of in Vivo Changes in Serotypes of Pseudomonas aeruginosa. Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 96, 294-298.

[15]   Singh, A., Goering, R.V., Simjee, S., Foley, S.L. and Zervos, M.J. (2006) Application of Molecular Techniques to the Study of Hospital Infection. Clinical Microbiology Reviews, 19, 512-530.

[16]   Sproer, C., Mendrock, U., Swiderski, J., Lang, E. and Stackebrandt, E. (1999) The Phylogenetic Position of Serratia, Buttiauxella and Some Other Genera of the Family Enterobacteriaceae. International Journal of Systematic Bacteriology, 49, 1433-1438.

[17]   Cao, B., Wang, M., Liu, L., Zhou, Z., Wen, S., Rozalski, A. and Wang, L. (2009) 16S-23S rDNA Internal Transcribed Spacer Regions in Four Proteus Species. Journal of Microbiological Methods, 77, 109-118.

[18]   Giammanco, G.M., Grimont, P.A., Grimont, F., Lefevre, M., Giammanco, G. and Pignato, S. (2011) Phylogenetic Analysis of the Genera Proteus, Morganella and Providencia by Comparison of rpoB Gene Sequences of Type and Clinical Strains Suggests the Reclassification of Proteus myxofaciens in a New Genus, Cosenzaea gen. nov., as Cosenzaea myxofaciens comb. nov. International Journal of Systematic and Evolutionary Microbiology, 61, 1638-1644.

[19]   Giammanco, G., Pignato, S., Grimont, P.A.D., Grimont, F. and Giammanco, G.M. Genotyping of the Genus Proteus by rpoB Sequence Analysis. Italian Journal of Public Health, 19-22.

[20]   Pignato, S., Giammanco, G.M., Grimont, F., Grimont, P.A. and Giammanco, G. (1999) Molecular Characterization of the Genera Proteus, Morganella, and Providencia by Ribotyping. Journal of Clinical Microbiology, 37, 2840-2847.